Dr Saralaya graduated from the University of Madras in 1989. He trained extensively in respiratory medicine and completed his higher speciality training both in India and on the Yorkshire respiratory training programme.
Dr Saralaya runs a severe asthma clinic at Bradford Teaching Hospitals NHS Foundation Trust for "difficult" asthma patients and has pioneered the use of Anti IgE therapy in severe allergic asthma in his NHS practice. He has authored publications on the role of anti IgE therapy in severe allergic asthma.
In 2000 Dr Saralaya was awarded the British Lung Foundation travel fellowship for his study on the role pleural fluid cytospin in the diagnosis of malignant pleural effusions and mesothelioma.
Dr Saralaya heads a respiratory clinical trials unit at the Bradford institute of Health Reasearch and is also a principle investigator in large multi-centre trials in newer therapies for COPD and Asthma. His unit have recruited first global patients into these trials for 3 consecutive years between 2011 and 2013. Dr Saralaya is the deputy research lead for respiratory medicine at the West Yorkshire research network and sits on the respiratory speciality group of the National Institute of Health Research.
He also has an interest in the management of sleep apnoea, running one of 3 centres in West Yorkshire treating patients with obstructive sleep apnoea.